STL Volume 10 Number 1
4 POSTS 0 COMMENTS
Update on Drugs and Drug News February 2005
Updates on: Alefacept AMEVIVE® Dapsone Gel 5% Aczone® Nitroglycerin Ointment Cellegesic® Cefdinir Oral Suspension Omnicef® Ultrasonic Skin Permeation
Device SonoPrep® Tazarotene Capsules
Clinical Use of RESTYLANE®
There is no ideal filler, nor will there be a single product that can satisfy all requirements. However, RESTYLANE®, a non-animal, stabilized hyaluronic acid (NASHA, Medicis), is a very versatile augmenting agent. It has been in clinical use for 8 years and experience has shown it to be close to the ideal filler in many respects.
Valacyclovir for the Management of Herpes Viral Infections
The Herpesviridae family (Types 1-8) continues to inflict considerable morbidity and social stigma upon humanity. Once infected with the herpes viruses, especially Types 1-3, they establish permanent residence within our nervous system and reactivate during periods of stress, trauma, and/or other precipitating factors.